Heart Failure Phased Pathway



Similar documents
Procedure for Inotrope Administration in the home

Heart Failure Clinical Pathway

Clinical Pathway Total Hip and Knee Replacement

CONGESTIVE HEART FAILURE PATIENT TEACHING

Heart Failure Outpatient Clinical Pathway

The new Heart Failure pathway

FIRST HOME VISIT. What barriers do you feel you may have in following these instructions?

ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY

Hypertension Guidelines

URN: Family name: Given name(s): Address:

URN: Family name: Given name(s): Address:

CORONARY ARTERY BYPASS GRAFT & HEART VALVE SURGERY

REMINDER: Please ensure all stroke and TIA patients admitted to hospital are designated as "Stroke Service" in Cerner.

Tackling the Semantic Interoperability challenge

IN-HOME QUALITY IMPROVEMENT BEST PRACTICE: PHYSICIAN RELATIONSHIPS NURSE TRACK

The Eating Disorder Program The Hospital for Sick Children

Chronic Obstructive Pulmonary Disease (COPD) Admission Order Set

Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria.

Quiz 5 Heart Failure scores (n=163)

Ischemic Stroke Clinical Pathway

Waterloo Wellington Rehabilitative Care System Integrated Care Pathway for COPD Stream of Care (short version)

Georgia Northwestern Technical College Practical Nursing Program CLINICAL DAILY ASSESSMENT WORKSHEET FOR MODULES I-IV STUDENT: CLINICAL INSTRUCTOR:

Drug Treatment in Type 2 Diabetes with Hypertension

TOTAL PARENTERAL NUTRITION (TPN) Revised January 2013

User guide Basal-bolus Insulin Dosing Chart: Adult

Successful Heart Failure Management Nurse/NP Run Clinics

Chronic Kidney Disease and the Electronic Health Record. Duaine Murphree, MD Sarah M. Thelen, MD

Hypertension and Heart Failure Medications. Dr William Dooley

CLINICAL PATHWAY FOR BREAST SURGERY: CONSERVING TREATMENT & MAJOR PROCEDURES

SOUTH EAST WALES CARDIAC NETWORK INTEGRATED CARE PATHWAY CARDIAC REHABILITATION MAY 2005

Manitoba EMR Data Extract Specifications

NUTRITION IN LIVER DISEASES

A Patients Guide to Heart Failure

Hypertension Best Practices Symposium

High Blood Pressure and Chronic Kidney Disease

High Blood Pressure and Chronic Kidney Disease. For People With CKD Stages 1 4

Upstate University Health System Medication Exam - Version A

Primary Care Quality Care Indicators - Accuro EMR Prevention

SPECIALTY : CARDIOLOGY CLINICAL PROBLEM: HEART FAILURE

Appendix L: HQO Year 1 Implementation Priorities

VCH PHCTF EVALUATION CORE INDICATORS, DATA COLLECTION PROCESSES, TOOLS & TARGETS

COPD - Education for Patients and Carers Integrated Care Pathway

Case Study 6: Management of Hypertension

Inpatient Heart Failure Management: Risks & Benefits

SYMPTOMS Heart failure symptoms may vary and can be hard to detect. Symptoms may include:

C1, C2 Continuing the Conversation: What is CRITICAL in providing comfort care?

Community health care services Alternatives to acute admission & Facilitated discharge options. Directory

Visual Acuity. Hearing. Height and Weight. Blood Pressure MEASURED VALUE

Management of High Blood Pressure in Adults Based on the Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC8)

High Blood pressure and chronic kidney disease

Performance Measurement for the Medicare and Medicaid Eligible (MME) Population in Connecticut Survey Analysis

Atrial Fibrillation Management Across the Spectrum of Illness

MEDICAL NUTRITION THERAPY (MNT) CLINICAL NUTRITION THERAPY Service Time CPT Code

Endovascular Abdominal Aortic Aneurysm Repair Surgery

ISSUED BY: TITLE: ISSUED BY: TITLE: President

North of Tyne Area Prescribing Committee

Baskets of Care Diabetes Subcommittee

2013 ACO Quality Measures

Hypertension Guideline V4

Board Review: Hypertension Cases

Universitätsklinik für Kardiologie. Test. Thomas M. Suter Akute Herzinsuffizienz Diagnostik und Therapie 1

KIH Cardiac Rehabilitation Program

Cardiovascular Risk in Diabetes

BCCA Protocol Summary for Palliative Treatment of Advanced Pancreatic Neuroendocrine Tumours using SUNItinib (SUTENT )

GFR (Glomerular Filtration Rate) A Key to Understanding How Well Your Kidneys Are Working

Clinical Care Program

Clinical Quality Measure Crosswalk: HEDIS, Meaningful Use, PQRS, PCMH, Beacon, 10 SOW

Cardiac Rehabilitation at AUBMC

Diabetes and Your Kidneys


AMBULATORY CARE SERVICES

Provision of Intravenous EDTA Chelation as a Complementary and Alternative Medicine

Heart Failure & Cardiac Rehabilitation

Supportive Cardiology: Living with Advanced Heart Failure A GUIDE FOR PATIENTS AND FAMILIES

1 Congestive Heart Failure & its Pharmacological Management

A PATIENT S GUIDE TO SECONDARY PREVENTION IN ACUTE CORONARY SYNDROME (ACS)

REFERENCE. Admit to: Program/Service: Diagnosis: Droplet/ Contact Airborne/ Contact

Suffolk County Community College School of Nursing NUR 133 ADULT NURSING I

Getting the most from blood pressure medicines

ACUTE STROKE UNIT ORIENTATION

Congestive Heart Failure

Congestive Heart Failure

Diabetic Nephropathy

Cardiovascular System & Its Diseases. Lecture #4 Heart Failure & Cardiac Arrhythmias

Congestive Heart Failure Management Program

Appendix i. All-Wales Cardiac Rehabilitation Pathway. All-Wales Cardiac Rehabilitation Group 2009

CLINICAL PROTOCOL THE MALNUTRITION UNIVERSAL SCREENING TOOL (MUST)

Cardiac Rehabilitation

Current Management of Atrial Fibrillation DISCLOSURES. Heart Beat Anatomy. I have no financial conflicts to disclose

Falls Management: Assessment & Intervention Approval Signature: September, 2012

Facilitating A Learning Environment

Transcription:

UNIVERSITY OF OTTAWA HEART INSTITUTE CLINICAL PATHWAY Heart Failure Phased Pathwa Addressograph/Plaque Acute Phase (Patient moves to transition phase once oral diuretic ordered) Date Initiated: m d Critical Path m d Patient Outcomes m d Tests Chest X-ra PA & Lateral ECG at admission, then PRN Consider Echo or Muga Hgb,WBC, platelets at admission, then Q Mon., Wed., Fri. Lipid profi e within 24 hrs of admission AST, ALT, ALP, albumin, uric acid, TSH at admission then as ordered Na, K, creat, glucose at admission and dail INR if on coumadin at admission & then as ordered Heparin as ordered Urine R&M During this phase the patient will verbalize if: Feeling better Less SOB Able to lie fl at Less peripheral, abdominal edema Objectivel the patient will: Be able to lie fl at Have less edema Be starting to mobilize Assessments/ Treatments VS QID and PRN Weight QAM after fi rst void and before breakfast Intake and output Titrate 0 according to protocol 2 Assess patient and famil understanding of Heart Failure Medications Diuretic if patient not losing 1 kg/da consider thiazide or an IV lasix infusion Betablocker ACE inhibitor or ARB Spironolactone Digoxin Consider inotrope if evidence of smptomatic hpotension or hpotension associated with poor diuretic response Consult Nutrition counseling for all Heart Failure patients Social work prn Pharmacist prn Occupational therap prn Phsiotherap exercise counseling onl Phsiotherap prn Smoking cessation as required Rehab referral Mobilit/Safet If on bedrest, explain reasons for: requesting help with ambulation; possible bedrails up & ring bell for help to bathroom Progress ambulation up in chair for meals, up to bathroom Increase ambulation in the halls Assess abilit for ADLs During the acute phase the patient should be losing 1 kg/da (1kg = neg 1 litre/da) Have stable Creatinine (creatinine should not be > 25% over baseline) Have no complaints of smptomatic hpotension Able to verbalize an understanding: ACE inhibitors decrease the work of the heart & lower BP Diuretics eliminate water & salt and decrease swelling Beta blockers decrease work of heart & lower BP and HR Consults: Phsio consult exercise onl Received Done Phsio consult prn Received Done Nutrition consult Received Done Smoking cessation consult Received Done Rehab referral consult Received Done Social work consult prn Received Done Pharmacist consult prn Received Done Occupational therap consult prn Received Done Patient able to increase activit as tolerated and shows increased tolerance for ADL UOHI 6 A (REV 07/2009)

Acute Phase (Patient moves to transition phase once oral diuretic ordered) Date Initiated: m d m d m d Critical Path Nutrition HI diet 2 Gm Na diet Diabetic diet Fluid restriction: 1.2 litres 1.5 litres Other Dail intake and output during acute phase Q shift Improved appetite Able to keep record of fl uid intake Patient Outcomes Discharge Planning Begin discussion with patient & famil about discharge issues & possible solutions Discuss with patient & famil the importance of owning a scale & ask if the have a scale if not suggest the purchase one with large numbers or digital scale Initiate HF GAP tool Patient Education Patient and famil are aware: Patient has heart failure To verbalize understanding of SOB, PND, ankle swelling, orthopnea Of reasons for thirst, weight monitoring, and salt/fl uid monitoring The need for a weigh scale at home Patient verbalizes an understanding of: ACE inhibitors decrease the work of the heart & lower BP Diuretics eliminate water and reduce swelling Beta blockers decrease work of heart & lower BP Comments: Date End of acute phase: m d m d m d UOHI 6 A (2 8)

Acute Phase Signature Sheet Date (aa / mm / dj) Signature of Da (0715 1915) Signature of Night (1915 0715) UOHI 6 A (3 8)

Transition Phase (Patient moves to maintenance phase when stable on oral diuretic and other medications) Date Initiated: m d m d m d Critical Path Tests Hgb, WBC, platelets at admission, then Q Mon., Wed., Fri. AST, ALT, ALP, albumin, uric acid, TSH as ordered Na, K, creat, glucose Mon., Wed., Fri. or as ordered INR if on coumadin dail & then as ordered For Heparin/LMWH see standard orders Assessments/ Treatments VS QID and PRN Weight QAM after fi rst void and before breakfast Intake Q shift Titrate 0 according to guidelines 2 Assess patient and famil understanding of Heart Failure Medications Diuretic Betablocker ACE inhibitor or ARB Spironolactone Digoxin Consult CCAC consult as necessar Telehome monitoring if appropriate Mobilit/ Safet Progress ambulation up in chair for meals, up to bathroom Increase ambulation in the halls Assess abilit for ADLs Nutrition HI diet 2 Gm Na diet Diabetic diet Fluid restriction: 1.2 litres 1.5 litres Other Dail intake Discharge Planning Plans for discharge should be fi nalized Continue updating HF GAP tool Patient will be started on oral diuretic Patient Outcomes During this phase the patient will verbalize: Feeling better Less SOB Able to lie fl at Less peripheral, abdominal edema Objectivel the patient will: Be able to lie fl at Have less edema Have improved exercise tolerance Be able to wean Oxgen Perform some ADLs independantl Able to verbalize an understanding: ACE inhibitors decrease the work of the heart & lower BP Diuretics eliminate water & salt and decrease swelling Beta blockers decrease work of heart and lower BP and HR Consults: Phsio consult exercise onl Received Done Phsio consult prn Received Done Nutrition consult Received Done Smoking cessation consult Received Done Rehab referral consult Received Done Social work consult prn Received Done Pharmacist consult prn Received Done Occupational therap consult prn Received Done CCAC consult prn Received Done Increase exercise tolerance Improved appetite Able to keep record of fl uid intake Patient Education Explain and reinforce during Transition Phase reasons for: Weight monitoring and self weight chart Ensure patient has weigh scale at home Salt/fl uid restriction Thirst and activit intolerance Heart failure medications Teach signs of condition change and when to contact a phsician Review all videos and teaching material Begin reviewing and populating the HF GAP tool Patient & famil aware: Patient has heart failure Able to verbalize understanding of SOB, PND, ankle swelling & orthopnea Of reasons for thirst, weight monitoring, salt/fl uid restriction Comments: Date End of transition phase: m d m d m d UOHI 6 A (4 8)

Transition Phase Signature Sheet Date (aa / mm / dj) Signature of Da (0715 1915) Signature of Night (1915 0715) UOHI 6 A (5 8)

Date Initiated: Maintenance Phase (Patient continues to be stable on oral diuretic and other medications) m d Critical Path m d Patient Outcomes m d Tests As ordered b phsician Assessments/ Treatments VS QID and PRN Weight QAM after fi rst void and before breakfast Assess patient and famil understanding of Heart Failure Medications Diuretic Betablocker ACE inhibitor or ARB Spironolactone Digoxin Patient & famil should receive information regarding discharge medications Consult Nutrition counseling for all patients Social work prn CACC consult prn Pharmacist prn Occupational therap prn Phsiotherap exercise counseling for all patients Phsiotherap prn Smoking cessation Home monitoring consult prn Rehab consult Mobilit/Safet Safe mobilit practices being reinforced with patient and famil Plans in place for safe discharge Nutrition HI diet 2 Gm Na diet Diabetic diet Fluid restriction 2 litres During this phase the patient will: Be stable on oral lasix Have stable weight Objectivel the patient will: Be able to lie fl at Have less edema Mobilize safel as tolerated Stable creatinine Stable BP Perform all ADLs independentl or at base level Patient and families can verbalize reasons for medications Consults are complete as needed Increase exercise tolerance Improved appetite Able to keep record of fl uid intake Patient and famil able to demonstrate safe mobilit practices if needed Patient and famil able to discuss the importance of monitoring fl uid and salt intake Discharge planning Reinforce all discharge plans & date with the famil Continue updating HF GAP tool Address all last minute concerns Patient Education Reinforce during Maintenance Phase: Weight monitoring and self weight chart Salt/fl uid restriction Thirst and activit intolerance Patient confi rms he/she has a weight scale Comments: Date End of maintenance phase: m d m d m d UOHI 6 A (6 8)

Maintenance Phase Signature Sheet Date (aa / mm / dj) Signature of Da (0715 1915) Signature of Night (1915 0715) UOHI 6 A (7 8)

UOHI 6 A (8 8)